Holding “national immunobiological company”, representing the pharmaceutical cluster of the state Corporation rostec, has fulfilled all commitments for the first phase of supply of preventive vaccines, used for the free universal immunization. Deliveries were carried out in the framework of the signed in may and June, the state contracts with the Russian Ministry of health totaling more than RUB 1.3 billion.
On 26 July the company shipped the last batch of pertussis-tetanus-tetanus vaccine (DPT), passing a total of over 2 million doses of the prophylactic drug. For the first time this year, the vaccine manufacturer, NPO “Microgen” – with the aim of strengthening quality control on translated the vaccine series-based selective quality control.
The main volume of single and multi-component combination vaccines list NKPP (prevention of viral hepatitis b, measles, mumps, rubella, tuberculosis, tetanus, pertussis and tetanus), amounting to almost 25 million doses have been made available to the customer in June 2018, ahead of schedule by almost a month. Express delivery was carried out in connection with a limited supply of drugs in the region.
The holding has already started to supply the vaccines in the second phase, it is planned that the main volume will be delivered to 30 October 2018.
“National immunobiological company” meets the needs of the Ministry of health of Russia in the domestic vaccine is produced in full cycle, from 2015. For three years as the only supplier holding delivered for state needs more than 260 million doses, half of them occurred in the influenza vaccine.